Skip to main content
Log in

Stroke pathophysiology: management challenges and new treatment advances

Fisiopatología del ictus: clásicos y nuevos tratamientos

  • Published:
Journal of Physiology and Biochemistry Aims and scope Submit manuscript

Abstract

Stroke is the second leading cause of death and the first cause of lost disability-adjusted years in developed countries. During the past decade, new developments in thrombolytic therapy have led to the implementation of emergency intervention protocols for the treatment of ischemic stroke, replacing the widespread sense of therapeutic nihilism in the past. Treatment with rtPA has shown to be effective within the first 3 hours following stroke onset and the FDA and the European Medical Agency (EMEA) have approved its use. Acknowledging the urgency and intricacies of stroke, Stroke Units allow the monitoring of physiological parameters in the acute phase of stroke and are considered an important management tool that can significantly improve the quality of care provided to the patient. The concept of neuroprotective therapy for acute ischemic stroke to salvage tissue at risk and improve functional outcome is based on sound scientific principles and extensive preclinical animal studies demonstrating efficacy. However, most neuroprotective drugs in clinical trials have failed, possibly due to inadequate preclinical testing or flawed clinical development programs. Several new treatment strategies are under development and are being tested. This review is directed at understanding the management of acute ischemic stroke pathophysiology. We address the management challenges and new treatment advances by integrating the knowledge of possible pharmacological targets for acute ischemic stroke. We hope to shed new light upon the controversy surrounding the management of acute ischemic stroke in an attempt to elucidate why failed clinical trials continue to occur despite promising neuroprotective preclinical studies.

Resumen

El ictus representa la segunda causa de muerte y la primera de incapacidad en los países desarrollados. Pese a su frecuencia y gravedad, hasta hace pocos años no se disponía de tratamientos eficaces en la fase aguda, lo que condicionaba una actitud nihilista en todo el proceso terapéutico. En la última década se ha conseguido demostrar la efectividad de la administración precoz de tratamiento intravenoso trombolítico con rtPA en el ictus isquémico, por lo que tanto la FDA americana como la agencia europea del medicamento han autorizado su uso, si bien con restricciones diferentes. Además, la monitorización de los parámetros biológicos y estandarización de los cuidados médicos y de enfermería en los primeros días, realizados en las Unidades de Ictus, han demostrado también su eficacia terapéutica. En la actualidad el esfuerzo investigador en el ictus intenta encontrar moléculas que solas o en combinación trasladen a la práctica clínica la capacidad de neuroprotección que muchas de ellas ya han demostrado en el laboratorio o en los modelos animales. Sin embargo, hasta la fecha este esfuerzo no ha sido recompensado plenamente y científicos básicos y clínicos tendrán que intensificar su trabajo y comunicación para lograr al fin estrategias que permitan mantener viable el tejido cerebral sometido a agresión tras el ictus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adams, H.P., Jr. (2002): Stroke, 33, 856–861.

    Article  CAS  PubMed  Google Scholar 

  2. Albers G.W., Bates, V.E., Clark W.M., Bell, R., Verro, P. and Hamilton, S.A. (2000): JAMA, 283, 1145–1150

    Article  CAS  PubMed  Google Scholar 

  3. Albers, G.W., Amarenco, P., Easton, J.D., Sacco, R.L. and Teal, P. (2001): Chest., 119, 300s-320s.

    Article  CAS  PubMed  Google Scholar 

  4. Albers, G.W., Amarenco, P., Easton, J.D., Sacco, R.L. and Teal, P. (2004): Chest., 126, 483s-512s.

    Article  CAS  PubMed  Google Scholar 

  5. Alexandrov, A.V., Molina, C.A., Grotta, J.C., et al. (2004): N. Engl. J. Med., 351, 2170–2178.

    Article  CAS  PubMed  Google Scholar 

  6. Alvarez-Sabin, J., Huertas, R., Quintana, M., Rubiera, M., Delgado, P., Ribo, M. et al. (2007): Stroke, 38, 1076–1078.

    Article  CAS  PubMed  Google Scholar 

  7. Bath, P.M., Iddenden, R., Bath, F.J. and Orgogozo, J.M. (2001): Cochrane Database Syst. Rev. CD002087

  8. Britton, M., De F.U. and Helmers, C. (1980): Acta Med. Scand., 207, 253–257.

    CAS  PubMed  Google Scholar 

  9. CAST (1997): Lancet, 349, 1641–1649.

    Article  Google Scholar 

  10. Choi, D.W. and Rothman, S.M. (1990): Annu. Rev. Neurosci., 13, 171–182.

    Article  CAS  PubMed  Google Scholar 

  11. Coull, B.M., Williams, L.S., Goldstein, L.B., Meschia, J.F., Heitzman, D., Chaturvedi, S. et al. (2002): Stroke, 33, 1934–1942.

    Article  CAS  PubMed  Google Scholar 

  12. Coull, B.M., Williams, L.S., Goldstein, L.B., Meschia, J.F., Heitzman, D., Chaturvedi, S. et al. (2002): Neurology, 59, 13–22.

    CAS  PubMed  Google Scholar 

  13. De Bruijn, S.F. and Stam, J. (1999): Stroke, 30, 484–8.

    PubMed  Google Scholar 

  14. De Georgia, M.A., Krieger, D.W., Abou-Chebl, A., Devlin, T.G., Jauss, M., Davis, S.M., et al. (2004): Neurology, 63, 312–317.

    PubMed  Google Scholar 

  15. Diener, H.C., Hacke, W., Hennerici, M., Radberg, J., Hantson, L. and De Keyser, J (1996): Stroke 27, 76–81.

    CAS  PubMed  Google Scholar 

  16. Díez-Tejedor, E. and Fuentes, B. (2004): Cerebrovasc. Dis., 17, 130–137.

    Article  PubMed  Google Scholar 

  17. Dippel, D.W., Van Breda, E.J., Van Gemert, H.M. et al. (2001): Stroke, 32, 1607–1612.

    CAS  PubMed  Google Scholar 

  18. Dippel, D.W., Van Breda, E.J., Van Gemert, H.M., Van Der Worp, H.B., Meijer, R.J., Kappelle, L.J. et al. (2001): Stroke, 32, 1607–1612.

    CAS  PubMed  Google Scholar 

  19. Einhaupl, K.M., Villringer, A., Meister, W., Mehraein, S., Garner, C., Pellkofer, M. et al. (1991): Lancet, 338, 597–600.

    Article  CAS  PubMed  Google Scholar 

  20. Einhaupl, K., Bousser, M.G., De Bruijn, S.F., Ferro, J.M., Martinelli, I., Masuhr, F. et al. (2006): Eur. J. Neurol., 13, 553–9.

    Article  CAS  PubMed  Google Scholar 

  21. Erecinska, M., Thorensen, M. and Silver, I.A. (2003): J. Cereb. Blood Flow Metab., 23, 515–530.

    Google Scholar 

  22. Fischberg, G.M., Lozano, E., Rajamani, K., Ameriso, S. and Fisher, M.J. (2000): J. Emerg. Med., 19, 339–346.

    Article  CAS  PubMed  Google Scholar 

  23. Flaherty, M.I. et al. (2005): Neurology, 64, 386–388.

    CAS  PubMed  Google Scholar 

  24. Fujii, K., Weno, B.L., Baumbach, G.L. and Heistad, D.D. (1992): Hypertension, 19, 713–716.

    CAS  PubMed  Google Scholar 

  25. Galindo, M.F., Jordan, J., Gonzalez-Garcia, C. and Cena V. (2003)Br. J. Pharmacol., 139, 797–804.

    Article  CAS  PubMed  Google Scholar 

  26. Ginsberg, M.D., Hill, M.D., Palesch, Y.Y., Ryckborst, K.J. and Tamariz, D. (2006): Stroke 37, 2100–6.

    Article  PubMed  Google Scholar 

  27. Ginsberg, M.D. (2003): Stroke, 34, 214–223.

    Article  PubMed  Google Scholar 

  28. Gomez-Lazaro M, Fernandez-Gomez, F.J. and Jordan J. (2004): J. Physiol. Biochem. 60, 287–307.

    Article  CAS  PubMed  Google Scholar 

  29. Gomez-Lazaro, M., Galindo, M.F., Melero-Fernandez de Mera, R.M., Fernandez-Gomez, F.J., Concannon, C.G., Segura, M.F., Comella, J.X., Prehn, J.H. and Jordan J. (2007): Mol. Pharmacol., 71, 736–743.

    Article  CAS  PubMed  Google Scholar 

  30. Grond, M., Stenzel, C., Schmulling, S. et al. (1998): Stroke, 29, 1544–1549.

    CAS  PubMed  Google Scholar 

  31. Hacke, W., Donnan, G., Fieschi, C. et al. (2004): Lancet, 363, 768–774.

    Article  PubMed  Google Scholar 

  32. Hacke W., Kaste, M., Fieschi, C., et al. (1998)Lancet, 352, 1245–1251

    Article  CAS  PubMed  Google Scholar 

  33. Hagerdal, M., Harp, J. and Siesjo, B.K. (1975): J. Neurochem., 24, 743–748.

    CAS  PubMed  Google Scholar 

  34. Jordan, J., Cena, V. and Prehn, J.H. (2003): J. Physiol. Biochem., 59, 129–141.

    Article  CAS  PubMed  Google Scholar 

  35. Jordan, J., Fernandez-Gomez, F.J., Ramos, M., Ikuta, I., Aguirre, N. and Galindo, M.F. (2007): Curr. Drug. Deliv., 4, 225–231.

    Article  CAS  PubMed  Google Scholar 

  36. Jordan, J., Galindo, M.F., Gonzalez-Garcia, C. and Cena V. (2003)Neuroscience, 122, 707–715.

    Article  CAS  PubMed  Google Scholar 

  37. Kaste, M., Hacke, W., Fieschi, C., et al. (1995): Cerebrovasc. Dis. 5, 225.

    Article  Google Scholar 

  38. Lampl, Y., Boaz, M., Gilad, R., Lorberboym, M., Dabby, R., Rapoport, A., Anca-Hershkowitz, M. and Sadeh, M. (2007): Neurology 69, 1404–1410.

    Article  CAS  PubMed  Google Scholar 

  39. Larrue, V., Von Kummer, R.R., Muller, A. and Bluhmki, E. (2001): Stroke 32, 438–441.

    CAS  PubMed  Google Scholar 

  40. Lavin, P. (1986): Arch. Intern. Med., 146, 66–68.

    Article  CAS  PubMed  Google Scholar 

  41. Lees Kr, Zivin Ja, Ashwood T, et al. (2006): N. Engl. J. Med., 354, 588–600.

    Article  CAS  PubMed  Google Scholar 

  42. Linsberg, P.J. and Roine, R.O. (2004): Stroke, 35, 363–364.

    Article  Google Scholar 

  43. Lipton, S.A. (2007): Curr. Drug. Targets., 8, 621–632.

    Article  CAS  PubMed  Google Scholar 

  44. Lisboa, R.C., et al. (2002): Stroke, 33, 2866–2871.

    Article  CAS  PubMed  Google Scholar 

  45. Lisk, D.R., Grotta, J.C., Lamki, L.M., Tran, H.D., Taylor, J.W., Molony, D.A. et al. (1993): Arch. Neurol., 50, 855–862.

    CAS  PubMed  Google Scholar 

  46. Luo, Y., Yin, W., Signore, A.P., Zhang, F. et al. (2006): J. Neurochem., 97, 435–448.

    Article  CAS  PubMed  Google Scholar 

  47. Marti-Fabregas, J., Gomis, M., Arboix, A., Aleu, A., Pagonabarraga, J., Belvis, R. et al. (2004): Stroke, 35, 1117–1121.

    Article  CAS  PubMed  Google Scholar 

  48. Mayer, S.A., Kowalski, R.G., Presciutti, M., Ostapkovich, N.D., Mcgann, E., Fitzsimmons, B.F., et al. (2004): Crit. Care Med., 32, 2508–2515.

    Article  PubMed  Google Scholar 

  49. Muir, K.W., Holzapfel, L. and Lees Kr. (2000): Cerebrovasc. Dis., 10, 431–436.

    Article  CAS  PubMed  Google Scholar 

  50. Muir, K.W., Lees, K.R., Ford, I. and Davis, S. (2004): Lancet, 363, 439–445.

    Article  CAS  PubMed  Google Scholar 

  51. Muir K.W. and Lees, K.R. (2003): Cochrane Database Syst. Rev., Cd001244.

  52. Nakashima, K. and Todd, M.M. (1996): Stroke, 27, 913–918.

    CAS  PubMed  Google Scholar 

  53. Nombela, F., Blanco, M., Moro, M.A., Rodriguez-Yañez, M., Leira, R., Lizosain, I. et al. (2006): Neurologia, 21, 539.

    Google Scholar 

  54. Norris, J.W. (2005): Stroke, 36, 2041–2042.

    Article  PubMed  Google Scholar 

  55. O’connell, J.E. and Gray, C.S. (1996): Drugs Aging, 8, 408–415.

    Article  PubMed  Google Scholar 

  56. Oliveira-Filho, J., Silva, S.C., Trabuco, C.C., Pedreira, B.B., Sousa, E.U. and Bacellar, A. (2003): Neurology, 61, 1047–1051.

    CAS  PubMed  Google Scholar 

  57. Palesch, Y.Y., Hill, M.D., Ryckborst, K.J., Tamariz, D. and Ginsberg, M.D. (2006): Stroke, 37, 2107–2114.

    Article  CAS  PubMed  Google Scholar 

  58. Pettigrew, L.C., Kasner, S.E., Albers, G.W., et al. (2006): J. Neurol. Sci., 251, 50–56.

    Article  CAS  PubMed  Google Scholar 

  59. Powers, W.J. (1993): Neurology, 43, 461–467.

    CAS  PubMed  Google Scholar 

  60. Ray, S.K. (2006): Curr. Med. Chem., 13, 3425–3440.

    Article  CAS  PubMed  Google Scholar 

  61. Rosenberg, G., Angel, I. and Kozak, A. (2005): Br. J. Clin. Pharmacol., 60, 7–16.

    Article  CAS  PubMed  Google Scholar 

  62. Sacco, R.L., Adams, R., Albers, G., Alberts, M.J., Benavente, O., Furie, K. et al. (2006): Circulation, 113, E409-E449.

    PubMed  Google Scholar 

  63. Saver, J.I., Kidwell, C., Eckstein, M. and Starkman, S. (2004): Stroke, 35, E106-E108.

    Article  CAS  PubMed  Google Scholar 

  64. Schrader, J., Luders, S., Kulschewski, A., Berger, J., Zidek, W., Treib, J. et al. (2003): Stroke, 34, 1699–1703.

    Article  PubMed  Google Scholar 

  65. Schwartz-Bloom, R.D., Miller, K.A., Evenson, D.A., Crain, B.J. and Nadler, J.V. (2000): Neuroscience, 98, 471–484.

    Article  CAS  PubMed  Google Scholar 

  66. Selim, M. and Caplan, L.R. (2004): Curr. Treat Options Cardiovasc. Med., 6, 249–253.

    Article  PubMed  Google Scholar 

  67. Sherman, D.G. (2004): Cerebrovasc. Dis., 17, 138–143.

    Article  CAS  PubMed  Google Scholar 

  68. Shin, D.H., Moon, G.J. and Bang, O.Y. (2007): J. Neurol., 254, 870–878.

    Article  CAS  PubMed  Google Scholar 

  69. Shuaib, A., Lees, K.R., Lyden, P., Grotta, J., Davalos, A., Davis, S.M., Diener, H.C., Ashwood, T., Wasiewski, W.W. and Emeribe, U: Saint Ii Trial Investigators. (2007): N. Engl. J. Med., 357, 562–571.

    Article  CAS  PubMed  Google Scholar 

  70. Smith, W.S., Sung, G., Starkman, S., et al. (2005): Stroke, 36, 1432–1438.

    Article  PubMed  Google Scholar 

  71. Stavrovskaya, I.G., Narayanan, M.V., Zhang, W., Krasnikov, B.F., Heemskerk, J., Young, S.S., Blass, J.P., Brown, A.M., Beal, M.F., Friedlander, R.M. and Kristal, B.S. (2004): J. Exp. Med., 200, 211–222.

    Article  CAS  PubMed  Google Scholar 

  72. Takahara, A., Konda, T., Enomoto, A. and Kondo, N. (2004): Biol. Pharm. Bull., 27, 1388–1391.

    Article  CAS  PubMed  Google Scholar 

  73. Takata, T., Nabetani, M. and Okada, Y. (1997): Neurosci. Lett., 227, 41–44.

    Article  CAS  PubMed  Google Scholar 

  74. Tanne D, Bates V, Verro P, et al. (1999): Neurology, 53, 424–427.

    CAS  PubMed  Google Scholar 

  75. Tanne, D., Kasner, S.E., Demchuk, A.M., Koren-Morag, N., Hanson, S., Grond, M. et al. (2002): Circulation, 105, 1679–1685.

    Article  CAS  PubMed  Google Scholar 

  76. The International Stroke Trial (Ist). (1997). Lancet, 349, 1569–1581.

    Article  Google Scholar 

  77. The National Institute of Neurological Disorders and Stroke. (1995): N. Engl. J. Med., 333, 1581–1587.

    Article  Google Scholar 

  78. Vlcek, M., Schillinger, M., Lang, W., Lalouschek, W., Bur, A. and Hirschl, M.M. (2003): Ann. Emerg. Med., 42, 619–626.

    Article  PubMed  Google Scholar 

  79. Wahlgren, N., Ahmed, N., Davalos, A., Ford, G.A., Grond, M., Hacke, W., Hennerici, M.G., Kaste M., Kuelkens, S., Larrue, V., Lees, K.R., Roine, R.O., Soinne, L., Toni, D. and Vanhooren, G., Sits-Most Investigators. (2007): Lancet, 369, 275–282. Erratum In: Lancet, 2007, 369, 826.

    Article  CAS  PubMed  Google Scholar 

  80. Wahlgren, N.G., Bornhov, S., Sharma, A. et al., For The Class Study Group (1999): J. Stroke Cerebrovasc. Dis., 8, 1–10.

    Article  Google Scholar 

  81. Wang, L.M., Yan, Y., Zou, L.J., Jing, N.H. and Xu, Z.Y. (2005): Cell. Res., 15, 387–393.

    Article  CAS  PubMed  Google Scholar 

  82. Yamaguchi, T., Sano, K., Takakura, K., Saito, I., Shinohara, Y., Asano, T. and Yasuhara H. (1998): Stroke, 29, 12–17.

    CAS  PubMed  Google Scholar 

  83. Yoon, S.S., Dambrosia, J., Chalela, J. et al. (2004): BMC Med., 23, 2–4.

    Google Scholar 

  84. Young, R.S., Zalneraitis, E.L. and Dooling, E.C. (1980): JAMA, 244, 1233–5.

    Article  CAS  PubMed  Google Scholar 

  85. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T. and Koistinaho, J. (1998): Proc. Natl. Acad. Sci. USA, 95, 15769–15774.

    Article  CAS  PubMed  Google Scholar 

  86. Zhang, L., Zhang, Z.G., Ding, G.L., Jiang, Q., Liu, X., Meng, H. et al. (2005): Circulation, 112, 3486–3494.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Jordán.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jordán, J., Ikuta, I., García-García, J. et al. Stroke pathophysiology: management challenges and new treatment advances. J. Physiol. Biochem. 63, 261–277 (2007). https://doi.org/10.1007/BF03165789

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03165789

Key words

Palabras clave

Navigation